Title of article :
Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists
Author/Authors :
Elfatih Elzein، نويسنده , , Rao Kalla، نويسنده , , Xiaofen Li، نويسنده , , Thao Perry، نويسنده , , Eric Parkhill، نويسنده , , Venkata Palle، نويسنده , , Vaibahv Varkhedkar، نويسنده , , Art Gimbel، نويسنده , , Dewan Zeng، نويسنده , , David Lustig، نويسنده , , Kwan-Leung Chan MD FRCPC، نويسنده , , Jeff Zablocki، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2006
Abstract :
A series of new 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as A2B-AdoR antagonists have been synthesized and evaluated for their binding affinities for the A2B, A1, A2A, and A3-AdoRs. 8-(1-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-1H-pyrazol-4-yl)-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione (4) displayed high affinity (Ki = 1 nM) and selectivity for the A2B-AdoR versus A1, A2A, and A3-AdoRs (A1/A2B, A2A/A2B, and A3/A2B selectivity ratios of 370, 1100, and 480, respectively). The synthesis and SAR of this novel class of compounds are presented herein.
Keywords :
adenosine , Antagonists , asthma
Journal title :
Bioorganic & Medicinal Chemistry Letters
Journal title :
Bioorganic & Medicinal Chemistry Letters